.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
QuintilesIMS
Moodys
US Department of Justice
Cipla
Novartis
Deloitte
Cantor Fitzgerald
Merck
Fuji

Generated: December 17, 2017

DrugPatentWatch Database Preview

Icodextrin - Generic Drug Details

« Back to Dashboard

What are the generic sources for icodextrin and what is the scope of icodextrin patent protection?

Icodextrin
is the generic ingredient in one branded drug marketed by Baxter Hlthcare and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Icodextrin has forty-three patent family members in sixteen countries.

There is one drug master file entry for icodextrin. One supplier is listed for this compound.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter HlthcareEXTRANEALicodextrinSOLUTION;INTRAPERITONEAL021321-001Dec 20, 2002RXYesYes► Subscribe► Subscribe► Subscribe
Baxter HlthcareEXTRANEALicodextrinSOLUTION;INTRAPERITONEAL021321-001Dec 20, 2002RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: icodextrin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter HlthcareEXTRANEALicodextrinSOLUTION;INTRAPERITONEAL021321-001Dec 20, 2002► Subscribe► Subscribe
Baxter HlthcareEXTRANEALicodextrinSOLUTION;INTRAPERITONEAL021321-001Dec 20, 2002► Subscribe► Subscribe
Baxter HlthcareEXTRANEALicodextrinSOLUTION;INTRAPERITONEAL021321-001Dec 20, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: icodextrin

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
4,886,789 Peritoneal dialysis and compositions for use therein► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: icodextrin

Country Document Number Estimated Expiration
Finland862563► Subscribe
JapanS6248701► Subscribe
Austria106410► Subscribe
Luxembourg90269► Subscribe
United Kingdom2132914► Subscribe
Denmark288586► Subscribe
United Kingdom8400523► Subscribe
United Kingdom2154469► Subscribe
Australia5881186► Subscribe
United Kingdom8300718► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Citi
Accenture
Deloitte
Express Scripts
Baxter
Colorcon
Federal Trade Commission
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot